| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0005 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.001 |